| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $-0.21 (Miss by $-0.02) |
| EPS GAAP Actual | $-0.21 (Miss by $-0.02) |
| Revenue Actual | $0.013294B |
| Revenue Surprise | Beat by $13.294M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.1794 |
| EPS GAAP Estimate | $-0.1794 |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.41 | 5.51 | 0.08884278 | 0.96593 | 3 |
| Dec 2028 | 0.232 | 9.74 | 0.232 | 0.232 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.21 | -0.00083 | 0.013294B | 28.69% | 13.29M |
| FQ2 2025 (Jun 2025) | -0.17 | 0.0357 | 0.011489B | -734.21% | 11.49M |
| FQ1 2025 (Mar 2025) | -0.16 | 0.04517 | 0.009889B | 100% | 9.89M |
| FQ4 2024 (Dec 2024) | 0 | 0.19642 | 0.009379B | 100% | 9.38M |
| FQ3 2024 (Sep 2024) | -0.14 | -1.68141 | 0.00948B | 100% | 9.48M |
| FQ2 2024 (Jun 2024) | 0.22 | 0.22 | 0.095842B | 100% | 95.84M |
| FQ1 2017 (Mar 2017) | -0.0018 | -0.0018 | 0B | NAN% | 0M |
| FQ2 2017 (Jun 2017) | -0.0018 | -0.0018 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.1794
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | -0.1791 | -- | -0.1791 | -0.1791 | 3 |
| FQ3 2026 (Jul 2026) | -0.1792 | -17.19 | -0.1792 | -0.1792 | 3 |
| FQ2 2026 (Jun 2026) | -0.1792 | 5.13 | -0.1792 | -0.1792 | 3 |
| FQ1 2026 (Mar 2026) | -0.1794 | 10.81 | -0.1794 | -0.1794 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 0B | -- | 0B | 0B | 4 |
| FQ3 2026 (Jul 2026) | 0B | -INF | 0B | 0B | 5 |
| FQ2 2026 (Jun 2026) | 0B | -INF | 0B | 0B | 5 |
| FQ1 2026 (Mar 2026) | 0B | -INF | 0B | 0B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.20917 | -0.21 | -0.00083 | 0.4% |
| FQ2 2025 (Jun 2025) | -0.2057 | -0.17 | 0.0357 | -21% |
| FQ1 2025 (Mar 2025) | -0.20517 | -0.16 | 0.04517 | -28.23% |
| FQ4 2024 (Dec 2024) | -0.19642 | 0 | 0.19642 | INF% |
| FQ3 2024 (Sep 2024) | 1.54141 | -0.14 | -1.68141 | 1201.01% |
| FQ2 2024 (Jun 2024) | 0.22 | 0.22 | 100% | |
| FQ1 2017 (Mar 2017) | -0.0018 | -0.0018 | 100% | |
| FQ2 2017 (Jun 2017) | -0.0018 | -0.0018 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.01B | $13.29M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.01B | $11.49M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.01B | $9.89M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.01B | $9.38M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.01B | $9.48M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.1B | $95.84M | 100% |
| FQ1 2017 (Mar 2017) | $0B | $0B | $0M | NAN% |
| FQ2 2017 (Jun 2017) | $0B | $0B | $0M | NAN% |